1 documents found
Information × Registration Number 0120U104542, R & D request Title A 46-week double-blind, placebo-controlled phase 3 study with a 6-week randomized withdrawal period of the study drug to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis. Head Katerenchuk Vitalii I., Registration Date 23-10-2020 Organization Ukrainian medical stomatological Academy popup.description1 study with a 6-week randomized withdrawal period of the study drug to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis popup.nrat_date 2024-12-10 Close
search.res_rk
A 46-week double-blind, placebo-controlled phase 3 study with a 6-week randomized withdrawal period of the study drug to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis.
Head: Katerenchuk Vitalii I.. A 46-week double-blind, placebo-controlled phase 3 study with a 6-week randomized withdrawal period of the study drug to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis.. Ukrainian medical stomatological Academy. № 0120U104542
1 documents found

Updated: 2026-03-19


Роздрукувати цю сторінку